Cardiovascular diseases, though crucial, constitute a smaller share compared to the other two indications, reflecting a more specialized approach in GLP-1 drug applications for these diseases
L.ChristiansenS
You are experiencing one of the most statistically overrepresented side effects of this medication
GLP-1 receptors are present in the brain, cerebral blood vessels, pancreas, heart, gastrointestinal tract, adipose tissue, kidney, and muscles, and consequently affect a variety of systems and processes [38,39,40]
Step 3: Factor Analysis: After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the GLP-1 Analogues market
10.1111/dom.12802 Summary Keywords type 2 diabetes, DPP-4 inhibitors, oral antidiabetic, incretin-based therapy, gliptin, combination therapy Citation Gallwitz B (2019) Clinical Use of DPP-4 Inhibitors